Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival.
Kristin Roseth AassTonje Marie Vikene NedalSiri Anshushaug BoumaSynne Stokke TryggestadEinar HaukåsTobias Schmidt SlørdahlAnders WaageTherese StandalRobin MjellePublished in: British journal of cancer (2022)
Overexpression of miR-105-5p in myeloma cells correlates with reduced OS, potentially improving prognostic risk stratification in multiple myeloma.